|
|
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
/ RecruitingNot ApplicableIIT In-vivo Bioequivalence Study of Palbociclib 125 mg Hard Capsules of The Test Drug (PALBRANCE®, Arena Hayat Danesh, Iran) in Compared with The Reference Drug (IBRANCE® 125 mg, Pfizer Inc. Ireland) In Iranian Healthy Volunteers
A randomized, double-blind , parallel groups, multi center, non-inferiority and phase III clinical trial to compare the Efficacy and Safety of Altelyse (bio-similar Alteplase) versus the brand Actilyse in Acute MI patients with ST elevation
/ SuspendedNot ApplicableIIT Pharmacokinetic evaluation and formulation of Ranolazine tablets in comparison with brand drug (RANEXA).
100 Clinical Results associated with Arena Life Science
0 Patents (Medical) associated with Arena Life Science
100 Deals associated with Arena Life Science
100 Translational Medicine associated with Arena Life Science